Loading...
Pharmacogenomics meets precision cardio-oncology: is there synergistic potential?
An individual’s inherited genetic makeup and acquired genomic variants may account for a significant portion of observable variability in therapy efficacy and toxicity. Pharmacogenomics (PGx) is the concept that treatments can be modified to account for these differences to increase chances of thera...
Saved in:
| Published in: | Hum Mol Genet |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Oxford University Press
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7574955/ https://ncbi.nlm.nih.gov/pubmed/32601683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/hmg/ddaa134 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|